Osteomimicry in prostate cancer: current understanding & future targeting
How were biosimilars discussed at ESMO 2017?
PROPHECY trial: AR-V7 CTCs as a biomarker in mCRPC
Straightforward study design: SPARTAN trial of apalutamide for nmCRPC
MONARCH 3 study: CDK4/6 inhibitors in the treatment of metastatic breast cancer
Angelo Di Leo